IMNN•benzinga•
IMUNON Announces Data From Phase 1/2 Trial Evaluating Intraperitoneal IMNN-001 In Combination With Neoadjuvant Chemotherapy In Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer. Will Be Published In Gynecologic Oncology
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 6, 2025 by benzinga